What did Quan Fu Biotech decide at its 2026 annual meeting?

It approved loss coverage, financial statements, charter amendments, full board renewal, asset management rule updates, and cash增资 for overseas depositary receipts.

Is Quan Fu Biotech planning to list overseas?

The approval of overseas depositary receipts suggests potential international listing or fundraising in the near future.

Who are the newly elected directors?

Directors: Lin Qun, Xu Wenqi, Guo Meihui, Zhang Zhenwu, Wei Yongdu, Anfu Dajiankang LP. Independent directors: Li Zhongxi, Guo Zongming, Cheng Shouzhen.

AI News NQ Analysis

Quan Fu Biotech Announces Key Resolutions from 115th Annual Shareholders' Meeting

NQ Score 79/100

N1 Content Completeness 9

AI Summary (NQ-processed)

Quan Fu Biotech held its 115th annual shareholders' meeting on June 12, 2026, approving key resolutions including the 114 fiscal year loss allocation, financial statements, charter amendments, full board renewal, and a cash增资 for issuing overseas depositary receipts.

AI Analysis

Frequently Asked Questions

Q: What did Quan Fu Biotech decide at its 2026 annual meeting?: A: It approved loss coverage, financial statements, charter amendments, full board renewal, asset management rule updates, and cash增资 for overseas depositary receipts.
Q: Is Quan Fu Biotech planning to list overseas?: A: The approval of overseas depositary receipts suggests potential international listing or fundraising in the near future.
Q: Who are the newly elected directors?: A: Directors: Lin Qun, Xu Wenqi, Guo Meihui, Zhang Zhenwu, Wei Yongdu, Anfu Dajiankang LP. Independent directors: Li Zhongxi, Guo Zongming, Cheng Shouzhen.